British Society of Gastroenterology endorsed guidance for the management of immune checkpoint inhibitor-induced enterocolitis

Guidance highlights gastrointestinal tract inflammation is a common and sometimes serious side-effect of immune checkpoint inhibitor therapy. Authors provide a consensus framework for rapid investigation and management of immune checkpoint inhibitor-induced enterocolitis.

Lancet Gastroenterology and Hepatology